Nanospectra Biosciences
Latest round
- Series A
Last raised
- Oct 2006
Total raised
- $1.7M
Investors
- 1
About Nanospectra Biosciences
Nanospectra Biosciences, Inc.Founded in 2002 and headquartered in Houston, US, Nanospectra Biosciences focuses on developing advanced therapies for oncology. The company has undergone significant development in its product offerings but has not reported any notable pivots in its business strategy.Nanospectra specializes in advanced medical technologies leveraging nanoshells, specifically focusing on its core product, the AuroLase Therapy System. This innovative system utilizes gold nanoshells to target and destroy cancerous tissues through laser-induced thermal therapy, providing a minimally invasive treatment option for patients. The end use cases primarily involve oncology, addressing various cancers while aiming to reduce collateral damage to surrounding healthy tissues. The AuroLase Therapy is particularly designed for use in the treatment of tumors located in sensitive areas, enhancing efficacy and safety.Nanospectra's revenue model is primarily based on direct sales of its proprietary AuroLase Therapy System to healthcare institutions and partnerships with medical facilities. Transactions typically involve the sale of the device along with accompanying service contracts for maintenance and training, ensuring that healthcare providers can effectively utilize the technology in patient care. The structure includes upfront payments for the equipment coupled with recurring revenue through service agreements. Pricing strategies may vary based on specific client needs and the scale of purchase, but details regarding individual pricing are confidential. The company is designing upcoming enhancements to the AuroLase Therapy System, although specific release dates have not been disclosed. Additionally, Nanospectra aims to expand its presence in Europe and other international markets by 2023, tapping into the rising demand for innovative cancer therapies.
Who invested in Nanospectra Biosciences
1 investor across 1 round
See all investors in Nanospectra Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 30, 2006
Amount
$1.7M
Investors
Questions about Nanospectra Biosciences
Who invested in Nanospectra Biosciences?
Nanospectra Biosciences has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nanospectra Biosciences raised?
Nanospectra Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nanospectra Biosciences last raise money?
Nanospectra Biosciences's most recent round on record is a Series A, in Oct 2006.
What does Nanospectra Biosciences do?
Nanospectra Biosciences is a biotechnology company.
Where is Nanospectra Biosciences headquartered?
Nanospectra Biosciences is headquartered in Houston, US.
Which VCs invest in companies like Nanospectra Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nanospectra Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nanospectra Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.